Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dermtech Inc (DMTK)

Dermtech Inc (DMTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,462
  • Shares Outstanding, K 34,623
  • Annual Sales, $ 15,300 K
  • Annual Income, $ -100,890 K
  • 60-Month Beta 2.52
  • Price/Sales 1.34
  • Price/Cash Flow N/A
  • Price/Book 0.37
Trade DMTK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.14
  • Most Recent Earnings $-0.56 on 02/29/24
  • Latest Earnings Date 05/02/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 192.61% ( +112.27%)
  • Historical Volatility 61.35%
  • IV Percentile 67%
  • IV Rank 18.15%
  • IV High 925.65% on 03/20/24
  • IV Low 30.01% on 09/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 16
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 1,774
  • Open Int (30-Day) 1,725

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.56
  • Number of Estimates 1
  • High Estimate -0.56
  • Low Estimate -0.56
  • Prior Year -1.02
  • Growth Rate Est. (year over year) +45.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5900 +10.19%
on 04/17/24
0.7300 -10.95%
on 03/28/24
-0.0370 (-5.38%)
since 03/19/24
3-Month
0.5900 +10.19%
on 04/17/24
1.3996 -53.55%
on 02/15/24
-0.6099 (-48.40%)
since 01/19/24
52-Week
0.5900 +10.19%
on 04/17/24
4.3600 -85.09%
on 04/20/23
-3.7699 (-85.29%)
since 04/19/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky Notifies DermTech, Inc.(DMTK) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK) of a class action securities lawsuit....

DMTK : 0.6562 (+11.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. - DMTK

/PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK). Such investors are...

DMTK : 0.6562 (+11.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. - DMTK

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK). Such investors are...

DMTK : 0.6562 (+11.03%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. - DMTK

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK). Such investors are...

DMTK : 0.6562 (+11.03%)
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position

All three healthcare stocks have soared this year, but their share prices may not be sustainable.

NNOX : 8.62 (-4.96%)
DMTK : 0.6562 (+11.03%)
VKTX : 62.71 (-3.03%)
Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat

Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.

MD : 9.03 (+2.50%)
VMD : 7.97 (+2.18%)
DMTK : 0.6562 (+11.03%)
CMPS : 8.40 (-0.24%)
DermTech, Inc. (DMTK) Reports Q1 Loss, Lags Revenue Estimates

DermTech, Inc. (DMTK) delivered earnings and revenue surprises of -13.33% and 4.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DMTK : 0.6562 (+11.03%)
BDSX : 1.2500 (unch)
DermTech Reports First-Quarter 2023 Financial Results

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its first-quarter 2023 financial...

DMTK : 0.6562 (+11.03%)
New Survey Data Reveals Nearly 75% of Consumers Have Not Had a Full Skin Exam Within the Past 12 Months

DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the release of new survey data...

DMTK : 0.6562 (+11.03%)
DermTech Announces Contract With New York Health Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a physician-founded,...

DMTK : 0.6562 (+11.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States.

See More

Key Turning Points

3rd Resistance Point 0.6643
2nd Resistance Point 0.6497
1st Resistance Point 0.6203
Last Price 0.6562
1st Support Level 0.5763
2nd Support Level 0.5617
3rd Support Level 0.5323

See More

52-Week High 4.3600
Fibonacci 61.8% 2.9199
Fibonacci 50% 2.4750
Fibonacci 38.2% 2.0301
Last Price 0.6562
52-Week Low 0.5900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar